Results 211 to 220 of about 365,681 (229)
Some of the next articles are maybe not open access.
Prostate-Specific Antigen in Prostatic Carcinoma
Urologia Internationalis, 1990To evaluate the clinical and prognostic value of prostate-specific antigen (PSA) for the detection of tumor and tumor growth after therapy, 520 sera from 246 patients with prostatic carcinoma, 990 sera from patients with BPH, and 1,488 sera from patients with other urological diseases were analyzed. The values ranged from 0.1 to 1,828.9 ng/ml.
C D, Jurincic +3 more
openaire +2 more sources
Prostate-Specific Antigen in Prostatic Cancer
American Journal of Clinical Oncology, 1988In an attempt to establish the value of prostate-specific antigen (PSA) in prostatic cancer, serum PSA measurements were performed in 600 patients, including 75 previously untreated prostatic cancer patients. The mean PSA levels in the benign prostatic hypertrophy (BPH) and cancer groups were highly significantly different, but less difference was ...
J C, Baron +5 more
openaire +2 more sources
Prostatitis and serum prostate-specific antigen
Current Urology Reports, 2005Prostatitis is an inflammatory condition of the prostate and has been divided into four categories according to the National Institutes of Health classification. This article reviews the various types of prostatitis and their effect on serum prostate-specific antigen levels.
Puneet, Sindhwani, Christopher M, Wilson
openaire +2 more sources
Urology, 1995
Prostate-specific antigen (PSA) has become the most useful serum tumor marker in the diagnosis and screening of prostate adenocarcinoma. The currently cited reference range of normal (0 to 4.0 ng/mL monoclonal) lacks both the sensitivity and specificity to be universally accepted as a screening test, and alternatives to serum PSA have been proposed ...
R E, el-Galley +6 more
openaire +2 more sources
Prostate-specific antigen (PSA) has become the most useful serum tumor marker in the diagnosis and screening of prostate adenocarcinoma. The currently cited reference range of normal (0 to 4.0 ng/mL monoclonal) lacks both the sensitivity and specificity to be universally accepted as a screening test, and alternatives to serum PSA have been proposed ...
R E, el-Galley +6 more
openaire +2 more sources
New England Journal of Medicine, 1987
After half a century of clinical application, the usefulness of prostatic acid phosphatase (PAP) as a marker for carcinoma of the prostate is being challenged. Historically the first of the "serum markers" for the presence of a human cancer,1 acid phosphatase is still measured in clinical laboratories all over the world.
openaire +2 more sources
After half a century of clinical application, the usefulness of prostatic acid phosphatase (PAP) as a marker for carcinoma of the prostate is being challenged. Historically the first of the "serum markers" for the presence of a human cancer,1 acid phosphatase is still measured in clinical laboratories all over the world.
openaire +2 more sources
Prostatic Specific Antigen and Benign Prostatic Hyperplasia
Scandinavian Journal of Urology and Nephrology, 1996The aim of this study on patients (n = 51) with urodynamically proven obstruction was to search for correlations between serological levels of prostatic specific antigen (PSA) and age of patients, volume of prostate and prostatic morphology as evaluated on transurethral resection specimens.
Atan, ALİ +4 more
openaire +3 more sources
1994
PSA is a 34-kDa 240-amino-acid glycoprotein produced exclusively by prostatic epithelial cells. PSA is a serine protease, is a member of the kallikrein gene family, and has a high sequence homology with human glandular kallikrein. It has chymotrypsin-, trypsin-, and esterase-like activities.
openaire +2 more sources
PSA is a 34-kDa 240-amino-acid glycoprotein produced exclusively by prostatic epithelial cells. PSA is a serine protease, is a member of the kallikrein gene family, and has a high sequence homology with human glandular kallikrein. It has chymotrypsin-, trypsin-, and esterase-like activities.
openaire +2 more sources
Deutsche medizinische Wochenschrift (1946), 1995
Prostate specific antigen (PSA) is a 34 000 Da molecular weight glycoprotein found exclusively in the prostate, prostatic fluid and seminal plasma.
openaire +3 more sources
Prostate specific antigen (PSA) is a 34 000 Da molecular weight glycoprotein found exclusively in the prostate, prostatic fluid and seminal plasma.
openaire +3 more sources
Australian family physician, 2012
This article forms part of our 'Tests and results' series for 2011 which aims to provide information about common tests that general practitioners order regularly. It considers areas such as indications, what to tell the patient, what the test can and cannot tell you, and interpretation of results.
openaire +3 more sources
This article forms part of our 'Tests and results' series for 2011 which aims to provide information about common tests that general practitioners order regularly. It considers areas such as indications, what to tell the patient, what the test can and cannot tell you, and interpretation of results.
openaire +3 more sources